Physician
Tower Urology INC
Tower Urology INC was paid $402K by Medicaid between Jan 2018 and Nov 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoTOWER UROLOGY INC
LOS ANGELES, CA 90048
LOS ANGELES, CA 90048
33aNPI1861422941assigned 07/04/2006
33bProvider typeRadiation Oncology Physician
28Total paid$402K
24GClaims54,306
24DCodes billed52
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Radiation Oncology Physician providers in California
Rank by total paid#7 of 51
Median peer was paid$50K
This provider vs. median8.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,915 | $48K | |
| 2019 | 9,996 | $71K | |
| 2020 | 6,823 | $82K | |
| 2021 | 5,982 | $82K | |
| 2022 | 3,286 | $69K | |
| 2023 | 6,092 | $29K | |
| 2024incomplete | 14,212 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 4,794 | 4,591 | $184K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 4,604 | 4,070 | $116K |
| 76775 | 7.1% | 3,037 | 2,983 | $29K | |
| 76857 | 3.8% | 3,100 | 3,023 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.9% | 285 | 284 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 3,298 | 2,628 | $11K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.6% | 2,027 | 1,984 | $11K |
| 99223 | Prolong inpt eval add15 m | 1.6% | 70 | 66 | $6K |
| 51741 | <1% | 871 | 852 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 222 | 140 | $2K |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | <1% | 1,146 | 1,095 | $2K |
| 76770 | <1% | 90 | 89 | $1K |
40 more codes
| 51728 | <1% | 291 | $1K | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 331 | $1K |
| 52281 | <1% | 381 | $999.66 | |
| 81000 | <1% | 5,204 | $933.94 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,351 | $835.69 |
| 64566 | <1% | 30 | $787.41 | |
| 84403 | <1% | 1,698 | $545.76 | |
| 51700 | <1% | 51 | $531.08 | |
| 84153 | <1% | 1,984 | $490.89 | |
| 82570 | <1% | 5,002 | $374.48 | |
| 80076 | <1% | 1,919 | $248.57 | |
| 80069 | <1% | 1,839 | $195.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 961 | $188.47 |
| 84270 | <1% | 800 | $179.30 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 794 | $155.53 |
| 51702 | <1% | 13 | $139.15 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 727 | $134.50 |
| 76872 | <1% | 83 | $133.94 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 64 | $114.46 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 829 | $94.43 |
| 84439 | <1% | 786 | $76.53 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 549 | $59.53 |
| 87077 | <1% | 627 | $50.41 | |
| 84550 | <1% | 910 | $49.51 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 104 | $40.53 |
| 82670 | <1% | 366 | $24.46 | |
| 84154 | <1% | 336 | $18.98 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14 | $14.54 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 14 | $12.63 |
| 87184 | <1% | 352 | $8.38 | |
| 83001 | 0% | 89 | $0.00 | |
| 86316 | 0% | 62 | $0.00 | |
| 95971 | 0% | 29 | $0.00 | |
| 83002 | 0% | 89 | $0.00 | |
| 87147 | 0% | 12 | $0.00 | |
| 82465 | 0% | 362 | $0.00 | |
| 80061 | Lipid panel | 0% | 279 | $0.00 |
| 83718 | 0% | 363 | $0.00 | |
| 1090F | 0% | 12 | $0.00 | |
| 84146 | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAKRAVAN, AZITA (CEO)